Articles

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid;Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid;Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid;Complutense University, Madrid
Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona
Hematology Department, Hospital Universitario Sanchinarro, Madrid
Hematology Department, Hospital Universitario Ramon y Cajal, Madrid
Complutense University, Madrid;Hematology Department, Hospital Universitario La Fe, Valencia
Complutense University, Madrid;Hematology Department, Hospital Universitario La Fe, Valencia
Department of Hematology, Hospital Universitario de Getafe, Madrid
Hematology Department, Hospital Universitario Principe de Asturias, Madrid
Hematology Department, Hospital Clínico San Carlos, IdISSC, UCM, Madrid
Hematology Department, Hospital Universitario de la Princesa, Madrid
Hematology Department, Hospital Universitario Severo Ochoa, Madrid
Hematology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid
Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona
Hematological Malignancies Clinical Research Unit, CNIO, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid;Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid;Complutense University, Madrid
Hematology Department, Hospital Universitario 12 de Octubre, Madrid;Hematological Malignancies Clinical Research Unit, CNIO, Madrid;Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid;Complutense University, Madrid
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.194712